Application of sodium chromonate as adjuvant in treatment of pancreatic cancer

The invention discloses application of sodium chromonate as an adjuvant in treatment of pancreatic cancer, and belongs to the technical field of biological medicine. Sodium chromate is used as an adjuvant to target tumor infiltrating mast cells to sensitize pancreatic cancer patients, gemcitabine ch...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PU NING, YIN HANLIN, XIE YUQI, LIU LIANG, WU WENCHUAN, LOU WENHUI, HE TAOCHEN, CHEN QIANGDA
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PU NING
YIN HANLIN
XIE YUQI
LIU LIANG
WU WENCHUAN
LOU WENHUI
HE TAOCHEN
CHEN QIANGDA
description The invention discloses application of sodium chromonate as an adjuvant in treatment of pancreatic cancer, and belongs to the technical field of biological medicine. Sodium chromate is used as an adjuvant to target tumor infiltrating mast cells to sensitize pancreatic cancer patients, gemcitabine chemotherapy and anti-PD-1 immunotherapy are used, sodium chromate is used as a mast cell stabilizer, and the sensitivity of pancreatic cancer to gemcitabine chemotherapy and anti-PD-1 immunotherapy can be safely and remarkably improved. According to the present invention, with the application of the sodium chromonate as the pancreatic cancer treatment adjuvant, the tumor volume after the gemcitabine combined anti-PD-1 antibody treatment can be significantly reduced, and the tumor recurrence and metastasis can be reduced so as to prolong the survival of the patient and improve the prognosis of the patient, such that the extremely high practical value is provided in the safety and the economy. 本发明公开了色苷酸钠作为佐剂在治疗胰腺癌中的应用
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116763773A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116763773A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116763773A3</originalsourceid><addsrcrecordid>eNqNikEKwjAQAHPxIOof1gd4KIHmXIriqSfvZdluMdLuhmTr-43gAzzNDMzeDV1KSyS0qAI6Q9EpbivQM-uqgsaABXB6bW8UgyhgmdFWrlHvhELfjgRUlfPR7WZcCp9-PLjz7fro7xdOOnJJSCxsYz80TRtaH4Lv_D_PBzJpNsg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Application of sodium chromonate as adjuvant in treatment of pancreatic cancer</title><source>esp@cenet</source><creator>PU NING ; YIN HANLIN ; XIE YUQI ; LIU LIANG ; WU WENCHUAN ; LOU WENHUI ; HE TAOCHEN ; CHEN QIANGDA</creator><creatorcontrib>PU NING ; YIN HANLIN ; XIE YUQI ; LIU LIANG ; WU WENCHUAN ; LOU WENHUI ; HE TAOCHEN ; CHEN QIANGDA</creatorcontrib><description>The invention discloses application of sodium chromonate as an adjuvant in treatment of pancreatic cancer, and belongs to the technical field of biological medicine. Sodium chromate is used as an adjuvant to target tumor infiltrating mast cells to sensitize pancreatic cancer patients, gemcitabine chemotherapy and anti-PD-1 immunotherapy are used, sodium chromate is used as a mast cell stabilizer, and the sensitivity of pancreatic cancer to gemcitabine chemotherapy and anti-PD-1 immunotherapy can be safely and remarkably improved. According to the present invention, with the application of the sodium chromonate as the pancreatic cancer treatment adjuvant, the tumor volume after the gemcitabine combined anti-PD-1 antibody treatment can be significantly reduced, and the tumor recurrence and metastasis can be reduced so as to prolong the survival of the patient and improve the prognosis of the patient, such that the extremely high practical value is provided in the safety and the economy. 本发明公开了色苷酸钠作为佐剂在治疗胰腺癌中的应用</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230919&amp;DB=EPODOC&amp;CC=CN&amp;NR=116763773A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230919&amp;DB=EPODOC&amp;CC=CN&amp;NR=116763773A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PU NING</creatorcontrib><creatorcontrib>YIN HANLIN</creatorcontrib><creatorcontrib>XIE YUQI</creatorcontrib><creatorcontrib>LIU LIANG</creatorcontrib><creatorcontrib>WU WENCHUAN</creatorcontrib><creatorcontrib>LOU WENHUI</creatorcontrib><creatorcontrib>HE TAOCHEN</creatorcontrib><creatorcontrib>CHEN QIANGDA</creatorcontrib><title>Application of sodium chromonate as adjuvant in treatment of pancreatic cancer</title><description>The invention discloses application of sodium chromonate as an adjuvant in treatment of pancreatic cancer, and belongs to the technical field of biological medicine. Sodium chromate is used as an adjuvant to target tumor infiltrating mast cells to sensitize pancreatic cancer patients, gemcitabine chemotherapy and anti-PD-1 immunotherapy are used, sodium chromate is used as a mast cell stabilizer, and the sensitivity of pancreatic cancer to gemcitabine chemotherapy and anti-PD-1 immunotherapy can be safely and remarkably improved. According to the present invention, with the application of the sodium chromonate as the pancreatic cancer treatment adjuvant, the tumor volume after the gemcitabine combined anti-PD-1 antibody treatment can be significantly reduced, and the tumor recurrence and metastasis can be reduced so as to prolong the survival of the patient and improve the prognosis of the patient, such that the extremely high practical value is provided in the safety and the economy. 本发明公开了色苷酸钠作为佐剂在治疗胰腺癌中的应用</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNikEKwjAQAHPxIOof1gd4KIHmXIriqSfvZdluMdLuhmTr-43gAzzNDMzeDV1KSyS0qAI6Q9EpbivQM-uqgsaABXB6bW8UgyhgmdFWrlHvhELfjgRUlfPR7WZcCp9-PLjz7fro7xdOOnJJSCxsYz80TRtaH4Lv_D_PBzJpNsg</recordid><startdate>20230919</startdate><enddate>20230919</enddate><creator>PU NING</creator><creator>YIN HANLIN</creator><creator>XIE YUQI</creator><creator>LIU LIANG</creator><creator>WU WENCHUAN</creator><creator>LOU WENHUI</creator><creator>HE TAOCHEN</creator><creator>CHEN QIANGDA</creator><scope>EVB</scope></search><sort><creationdate>20230919</creationdate><title>Application of sodium chromonate as adjuvant in treatment of pancreatic cancer</title><author>PU NING ; YIN HANLIN ; XIE YUQI ; LIU LIANG ; WU WENCHUAN ; LOU WENHUI ; HE TAOCHEN ; CHEN QIANGDA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116763773A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PU NING</creatorcontrib><creatorcontrib>YIN HANLIN</creatorcontrib><creatorcontrib>XIE YUQI</creatorcontrib><creatorcontrib>LIU LIANG</creatorcontrib><creatorcontrib>WU WENCHUAN</creatorcontrib><creatorcontrib>LOU WENHUI</creatorcontrib><creatorcontrib>HE TAOCHEN</creatorcontrib><creatorcontrib>CHEN QIANGDA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PU NING</au><au>YIN HANLIN</au><au>XIE YUQI</au><au>LIU LIANG</au><au>WU WENCHUAN</au><au>LOU WENHUI</au><au>HE TAOCHEN</au><au>CHEN QIANGDA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Application of sodium chromonate as adjuvant in treatment of pancreatic cancer</title><date>2023-09-19</date><risdate>2023</risdate><abstract>The invention discloses application of sodium chromonate as an adjuvant in treatment of pancreatic cancer, and belongs to the technical field of biological medicine. Sodium chromate is used as an adjuvant to target tumor infiltrating mast cells to sensitize pancreatic cancer patients, gemcitabine chemotherapy and anti-PD-1 immunotherapy are used, sodium chromate is used as a mast cell stabilizer, and the sensitivity of pancreatic cancer to gemcitabine chemotherapy and anti-PD-1 immunotherapy can be safely and remarkably improved. According to the present invention, with the application of the sodium chromonate as the pancreatic cancer treatment adjuvant, the tumor volume after the gemcitabine combined anti-PD-1 antibody treatment can be significantly reduced, and the tumor recurrence and metastasis can be reduced so as to prolong the survival of the patient and improve the prognosis of the patient, such that the extremely high practical value is provided in the safety and the economy. 本发明公开了色苷酸钠作为佐剂在治疗胰腺癌中的应用</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN116763773A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Application of sodium chromonate as adjuvant in treatment of pancreatic cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T03%3A00%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PU%20NING&rft.date=2023-09-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116763773A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true